GINO BIOW Share Price Nasdaq
Equities
DNA
US37611X1000
Biotechnology & Medical Research
Sales 2024 * | 223M 17.87B | Sales 2025 * | 310M 24.8B | Capitalization | 1.72B 138B |
---|---|---|---|---|---|
Net income 2024 * | -631M -50.51B | Net income 2025 * | -534M -42.75B | EV / Sales 2024 * | 4.68 x |
Net cash position 2024 * | 676M 54.13B | Net cash position 2025 * | 550M 43.99B | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
-2.69
x | P/E ratio 2025 * |
-3.17
x | Employees | 1,218 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.98% |
Latest transcript on GINO BIOW
Managers | Title | Age | Since |
---|---|---|---|
Austin Che
FOU | Founder | - | 31/12/07 |
Founder | - | 31/12/07 | |
Reshma Shetty
FOU | Founder | 43 | 31/12/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 15/09/21 |
Marijn Dekkers
CHM | Chairman | 65 | 15/09/21 |
Kathy Hannan
BRD | Director/Board Member | 62 | 01/08/22 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |